CHENNAI: Swiss-pharma major Novartis AG said early this week that its pediatric malaria treatment, Coartem Baby, received regulatory approval from Swissmedic, Switzerland's national medicines ...

The company raised $54.5 million to make treatments that restore protein function in polycystic kidney disease ...